BASF DRUCKSYSTEME GMBH – Trademark Portfolio
Entity Type: 03
BASF DRUCKSYSTEME GMBH holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 2 (Paints) — 13 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include K+E, NOVAVIT, NOVACOAT, NOVASTAR, and NYLOSOLV. The owner is based in STUTTGART.
STUTTGART , DE
Showing of trademarks Trademarks
Trademark Classifications
BASF DRUCKSYSTEME GMBH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does BASF DRUCKSYSTEME GMBH have?
BASF DRUCKSYSTEME GMBH has 17 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned, 9 cancelled.
What trademark classes does BASF DRUCKSYSTEME GMBH file in?
BASF DRUCKSYSTEME GMBH files trademarks across 3 Nice Classification classes. The most active classes are Class 2 (Paints), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 2 covers paints, varnishes, lacquers; preservatives against rust and against deterioration of wood.
What are BASF DRUCKSYSTEME GMBH's most well-known trademarks?
BASF DRUCKSYSTEME GMBH's registered trademark portfolio includes well-known marks such as K+E, NOVAVIT, NOVACOAT, NOVASTAR, and NYLOSOLV. These are among 6 currently registered trademarks in the portfolio.
What is BASF DRUCKSYSTEME GMBH's trademark registration success rate?
BASF DRUCKSYSTEME GMBH has a 35% trademark registration rate, with 6 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.